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tYM and alzheiMer's disease

More testing needed
Although the test your memory (TYM) test for detecting Alzheimer's disease is self administered, 1 it was given out by clinic staff to referred clinic attendees with comparisons provided for defined clinical subgroups. The people filling in the questionnaires had already seen their general practitioner, and were seen immediately afterwards by a clinician who could address any concerns. The danger of calling a test self administered in the title of a paper is that it encourages downloading from the internet and doing it at home without interpretation or support. The diagnosis of dementia requires multidisciplinary assessement, often over a period of time.
2
TYM was administered to a comparatively young population (median age under 70) with potentially high educational levels; memory clinic referrals have not been shown to be representative of the general older population. TYM's advantage over the mini mental state examination (MMSE) is uncertain as the full MMSE receiver operator curve was not provided. These factors mean that TYM should not be assumed to perform as well in general practice waiting rooms or at home. If this is the intention for this test it must be applied in many different and appropriate settings, with longitudinal follow-up to ensure validity, as well as appropriate support to those completing it.
Too many false positives
Brown and colleagues report 93% sensitivity and 86% specificity for their self administered screening test for Alzheimer's disease.
1 They conclude that "it is a powerful and valid screening test for the detection of Alzheimer's disease."
However, doctors and lay people are often confused by such conditional probabilities, 2 3 and the value of a screening test is best appreciated when statistics are expressed in natural frequencies. For infrequent disorders, even high values of sensitivity and specificity can lead to an unacceptable number of false positives.
The accompanying editorial gives an expected prevalence of 13 cases of Alzheimer's disease in 1000 people aged 65-69. 4 Using this as the base rate together with the figures for sensitivity and specificity, I calculated test results in natural frequencies. For every individual correctly declared to have Alzheimer's disease, about 11, on average, will be falsely declared to have this dread disease.
This test is likely to become popular among doctors and lay people, given its ease of administration and the frequency with which the important question "Do I have Alzheimer's?" arises. The dissemination of the test would be unfortunate because the potential for misunderstanding its results is high, and will lead to many people incorrectly assessing or being told that they have a cruel disorder for which there is no hope. Age profile?
I wondered why Brown and colleagues have incorporated so many young people in their cross sectional control sample (including 18 year old volunteers whose risk of Alzheimer's disease is infinitesimal).
1 The presence of ceiling effects and age effects in the control data means that younger people will be more likely to score at the top of the scale-and the psychometric properties of the test your memory (TYM) test could be unwittingly distorted by the inclusion of so many junior participants.
Older people with presumed Alzheimer's disease tended to score more highly than younger people. That older controls tended to fare worse than younger people is worrying, although the pairwise statistical comparisons between age-matched controls and suspected Alzheimer's cases are reassuring. However, cut off scores/centile distributions and receiver operator characteristic curves would be helpful for the age groups at highest risk.
letters
Diagnoses can be meddlesome
Nicholl wrote: "Without a diagnosis, patients and carers cannot access the services they need." Echoing the National Dementia Strategy, she uses this as justification for early diagnosis of dementia.
1
We don't have to organise services in this way. Any diagnosis should always require this careful judgment: Will giving this label to this person at this time do more good than harm? It's like drawing a line in the sand. Diagnosis belongs to disease theory and is only one of many ways of categorising suffering. The diagnosis of dementia has serious implications for the future of a family; an early firm diagnosis is often elusive and early medical treatments remain marginally helpful. If the key early interventions are social and emotional support then why medicalise early symptoms? They should be socialised instead, and the emphasis placed on support services. Why make access to these contingent on a formal medical diagnosis? In our eagerness to do good and to be seen to be doing good, we risk drawing our line in the sand in a place that is meddlesome. 
Authors' reply
The test your memory (TYM) test is intended to be self administered by the patient-allowing testing of 10 cognitive skills in minimal operator time-but it needs to be overseen and interpreted by a health professional. 1 The test is therefore self administered but not for self diagnosis. It is hard to choose an alternative title which clarifies this without being too long. As a result of the publicity concerning self testing we have delayed the launch of the website tymtest.com until we can ensure easy access for professionals while discouraging self testing.
The TYM test has been validated in a single study in a single population presenting with cognitive problems, and shows great promise as a screening tool in this setting. Problems would occur with indiscriminate screening of asymptomatic patients, with many false positives. We agree that such testing is not appropriate. A low TYM score suggests the need to look for a cause, it does not mean the patient has Alzheimer's disease. We agree that the TYM test needs to be validated in other populations. Longitudinal data are crucial and are being collected.
The TYM test is not a diagnostic test. The diagnosis of Alzheimer's disease needs a proper clinical assessment from a trained professional. The TYM test is an aid in this process but not a replacement for it. Human beings and brain diseases are inherently variable, and a quick memory test which would allow an untrained person to safely diagnose Alzheimer's disease or distinguish Alzheimer's disease from other forms of degenerative or vascular dementia is unlikely ever to exist. An experienced clinician may recognise a pattern of scoring on the TYM which suggests Alzheimer's disease or semantic dementia in many patients.
We include a wide age range of controls because many younger patients have cognitive complaints as a result of epilepsy, multiple sclerosis, and other conditions, and we believe the TYM test may be useful in these patients. The average TYM scores of controls are remarkably stable but do fall off after the age of 70, as do most similar tests. There were no significant differences between older and younger patients with Alzheimer's disease.
We are well aware of the ethical debate around early diagnosis of Alzheimer's disease and share many of the concerns of correspondents. Progress towards early diagnosis must be made for several reasons. If a treatment that halts Alzheimer's disease becomes available, we need a test to identify those likely to benefit. 
Physicians have been involved
In 2007 I was invited to examine the detainee log of an inmate of Guantanamo to provide a medical opinion on whether the treatment amounted to torture. 1 It has now been concluded that it did.
2 My scrutiny found that medical staff not only were present during the interrogation but also made no attempt to intervene to stop it. A military radiologist was even flown in to report on a computed tomogram taken when the detainee became seriously dehydrated from hunger strike. Newly declassified legal memos from 2002 and 2005 concluded that certain "enhanced interrogation techniques" did not constitute torture, partly based on the assurance that medical personnel would be on hand to ensure that the techniques used did not cause "severe pain or suffering."
3 The Red Cross report leaked in April details the involvement of medical personnel present at and supplying medical interventions during the use of these enhanced techniques, some of which it describes as torture.
4
This seems clear evidence that military medical personnel acted in contravention to the Declaration of Tokyo that a "physician shall not be present during any procedure during which torture or any other forms of cruel, inhuman or degrading treatment is used or threatened." I do not therefore understand how Pope and Gutheil can assert that "physicians limited their involvement in detainee interrogations to such a degree that they prohibited even monitoring an interrogation with intent to intervene" and that "physicians do not design interrogation plans for specific detainees or observe interrogations with the intent to intervene because this undermines the physician's role as healer."
5
Physicians have no grounds to feel superior to psychologists: to date, no US military physician has had a licence to practise revoked as a consequence of their involvement, whatever the policies of the American Medical Association. 
Authors' reply
We appreciate Seltzer's thoughtful comments.
1
In our article "Contrasting ethical policies of physicians and psychologists concerning interrogation of detainees," we examined the ethical policies of the American Medical Association (AMA) and American Psychological Association (APA).
2 What Seltzer describes as our erroneous conclusions are our restatement of AMA's formal ethical policy.
For example, Seltzer quotes us as saying "physicians do not . . . observe interrogations with the intent to intervene because this undermines the physician's role as healer." However, we wrote: "Priscilla Ray, chair of the American Medical Association (AMA) council on ethical and judicial affairs, stated: 'Physicians must not conduct, directly participate in, letters the symptoms are generally non-specific, general practitioners can identify a significant proportion of women requiring investigation. In the GP records of a recent cohort from Devon, soon to be published in the BMJ, 196 of the 212 women with primary ovarian cancer had either a symptom recorded or a mass noted before diagnosis. Eighty eight were referred for investigation on the same day as the first symptom was recorded, with a further 36 within the next week. This leaves a minority of women who experience diagnostic delays in primary care and who would benefit from a lowering of the threshold for investigation.
However, the performance of CA125 measurement has not been studied in primary care. In a recent UK screening trial 8.6% of women had an initially raised CA125 concentration. 4 Most of them had normal results on repeat testing, but in the low prevalence setting of primary care many false positive results would be generated for each true positive. The potential adverse effects of a false positive result for ovarian cancer are not only the emotional considerations but also the risk of biopsy, or even oophrectomy, to achieve peace of mind. False positive results on ultrasound scanning were less common in the screening trial, so ultrasonography should remain the preferred investigation in primary care. Macpherson found an institutional problem of racism in the Metropolitan Police. The NHS seems to have an institutional problem about safety. Surely the failure of all the safety mechanisms at local, regional, and national levels in Staffordshire demand wider investigation than the narrow focus on the trust by the select committee, and the anecdotal approach of a recent conference. That the responsible heads of the NHS suggest juniors should "make waves" seems superficial. Senior medical and nursing staff at Stafford tried to make waves, and were not heard. It is surely not for the trust and its staff alone to "stand up for safety." What was happening at the primary care trust, which commissioned health care from the trust and should have been listening to the community and the staff? Did it not hear or see the waves? Perhaps the local MP has a role in ensuring safe health care for constituents. Is safety of no concern to the strategic health authority? Monitor should have a broader view of performance than purely financial issues, and the Health Care Commission itself seems to have been slow to recognise problems that were common knowledge and of concern to medical and nursing staff. A lot of waves were made, but no one in the organisation with responsibility for oversight was able to see or hear them.
The organisation as a whole seems not to have a systemic approach that makes safety a priority. Unlike flying, health care cannot be made entirely risk free, but present approaches seem to verge on the futile. The chief medical officer reported high risks of a fatal outcome, but in five years seems to have been unable to do anything about a potentially fatal hazard in drug administration. At these accident rates, the NHS's performance would surely be regarded as unacceptable if it was responsible for running an airline. Airbus and Boeing would be expected to respond more promptly to a design issue.
The NHS, a significant customer, seems unable to exert any power as a commissioner. We need to look further than the problems of what was clearly an over-ambitious trust. Encouraging junior doctors to raise concerns is laudable, but it may take attention away from more fundamental issues. We need something better from our commissioners and higher management. or monitor an interrogation with an intent to intervene, because this undermines the physician's role as healer.'" Physicians who conducted, directly participated in, or monitored an interrogation with an intent to intervene violated AMA's explicit ethical prohibition.
APA's ethical policies differed significantly. As our article documented, APA claimed that psychologists, unlike physicians, were uniquely qualified for this work, "knew not to participate in activities that harmed detainees," and were contributing to national security.
Works The evidence suggests that whistleblowers who report concerns are treated no better in the NHS now than at the time of the scandal at Bristol Royal Infirmary.
3 Medical leaders are responsible for the culture of silence. To become a medical leader one needs to compromise principles for expediency to meet the demands of politicians (in an organisation or government) with the power to advance or destroy a career. Medical leaders lack moral authority because few of them have taken the risk of speaking out on their way to the top. They are too often complicit in concealment of problems to protect their organisations or political masters. 4 Fiona Godlee spoke at the conference and represented the BMJ.
1 The BMJ has removed from its website articles that have appeared in the paper journal purely to avoid the risk of the journal being sued for libel. The articles have not been retracted because there are no grounds for retraction of truthful reports. Does the BMJ want junior doctors to take the risk of losing their careers by speaking out when it is afraid of the financial cost of speaking?
Liam Donaldson also spoke at the conference.
1 I have had correspondence and meetings with the chief medical officer to discuss misconduct by doctors, but I am left with the impression that he is unwilling or unable to act when the allegations involve senior medical leaders. Yet Sir Liam wants junior doctors to be brave enough to speak about problems.
The motivational speeches of medical leaders to junior doctors seem to be like the pep talks of generals to soldiers at the Somme before the troops went over the top and the leaders returned to their chateau for lunch. Medical leaders must now lead from the front and share the risks.
